JULIA MOSES: Open Payments
NPI 1982368320 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 52 payments from 10 companies in 2025. Trend: 2023 $464 · 2024 $586 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $383 |
| Madrigal Pharmaceuticals | 5 | $245 |
| QOL Medical, LLC | 9 | $181 |
| Ardelyx, Inc. | 3 | $77 |
| Janssen Biotech, Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 6 | $51 |
| GENZYME CORPORATION | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REZDIFFRA, MAVYRET, Sucraid, RINVOQ, IBSRELA, TREMFYA, VOQUEZNA, DUPIXENT.
Industry payments across KY — which companies pay providers there.
